T
Timothy J. Craig
Researcher at Pennsylvania State University
Publications - 493
Citations - 21287
Timothy J. Craig is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Hereditary angioedema & Asthma. The author has an hindex of 69, co-authored 458 publications receiving 18340 citations. Previous affiliations of Timothy J. Craig include University of Bristol & San Diego State University.
Papers
More filters
Journal ArticleDOI
Peri-adolescent asthma symptoms cause adult anxiety-related behavior and neurobiological processes in mice.
Jasmine I. Caulfield,Michael J. Caruso,Kerry C. Michael,Rebecca A. Bourne,Nicole R. Chirichella,Laura Cousino Klein,Timothy J. Craig,Robert H. Bonneau,Avery August,Sonia A. Cavigelli +9 more
TL;DR: This is the first evidence that experimentally‐induced clinical symptoms of adolescent asthma alter adult anxiety‐related behavior and brain function several weeks after completion of asthma manipulations.
Journal ArticleDOI
Reliability of skin test results when read at different time points.
TL;DR: Skin testing to determine IgE-mediated or immediate hypersensitivity can be read up to 30 minutes without significant loss of reliability, and SPTs can beRead up to 40 minutes after placement but are more reliable when read between 20 and 30 Minutes after placement.
Journal ArticleDOI
The relationship between insect sting allergy treatment and patient anxiety and depression.
Sarah Findeis,Timothy J. Craig +1 more
TL;DR: It appears that VIT not only decreases the risk of anaphylaxis and death, but also improves quality of life by reduction of anxiety and depression, especially in female subjects.
Journal ArticleDOI
Asthma and the diver.
TL;DR: Under the right circumstances, the patient with asthma can safely participate in recreational diving without apparent increased risk of an asthma-related event, according to the currently available literature.
Journal ArticleDOI
Recent advances in the management of hereditary angioedema.
TL;DR: Current and novel treatments for patients with HAE are reviewed, including C1 INH replacement drugs and medications aimed at components of the contact system (eg, plasma kallikrein inhibitor and bradykinin B2 receptor antagonist).